A large multinational clinical trial has found that giving health care providers access to European Organization for Research and Treatment of Cancer (EORTC) patient-reported outcome (PRO) data significantly improves the consistency of how treatment-related side effects are assessed in patients with cancer. The findings highlight the importance of integrating the patient’s voice into routine clinical evaluations and cancer research.
Continue Reading this article here
